SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: drrawmd65, BigKahuna, Steady_T, NewMoney, drkazmd65
Search This Board:
Last Post: 10/21/2016 2:20:47 PM - Followers: 466 - Board type: Free - Posts Today: 3

NanoViricides, Inc (NNVC)

Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
CIK:  0001379006
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
Recent News:

Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:

SEC Filings:
Share Structure:  See SEC filings for current share structure
Investor Relations:
Amanda Schuon, 310-550-7200


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NNVC News: NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials 10/11/2016 07:00:00 AM
NNVC News: Annual Report (10-k) 09/16/2016 04:53:47 PM
NNVC News: NanoViricides to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City Today 09/13/2016 12:01:00 AM
NNVC News: NanoViricides Reports on Senator Murphy's Visit to the Company's Shelton Campus 08/25/2016 07:00:00 AM
NNVC News: NanoViricides Reports On Progress of Its Drug Candidates against Herpesviruses 06/20/2016 07:00:00 AM
#123538  Sticky Note "One of the main reasons big pharma would Nanotoday 08/10/16 04:46:11 AM
#123144  Sticky Note DreamTeamNetwork email this morning on NNVC leifsmith 07/20/16 08:34:08 AM
#122302  Sticky Note Good grief. If Seymour and Diwan had arvitar 06/17/16 06:16:40 PM
#120585  Sticky Note Well Said! MJJONES 04/28/16 08:35:40 PM
#125909   Currently below support. Rut roe, someone better NewMoney 10/21/16 11:06:59 AM
#125907   After all, no one has ever attempted and Its_lose_not_loose 10/20/16 08:53:14 PM
#125906   Yeah, that's worked really well for NNVC. arvitar 10/20/16 08:30:56 PM
#125905   As I keep saying, the fly in the BigKahuna 10/20/16 08:27:09 PM
#125904   A biopharma startup doesn't need a scientist as BigKahuna 10/20/16 08:06:29 PM
#125903   Someone doesn't suddenly become a lying con man arvitar 10/20/16 05:51:35 PM
#125902   I believe Seymour has had ample time to Its_lose_not_loose 10/20/16 05:35:08 PM
#125901   Seymour has successfully made $70M vanish. arvitar 10/20/16 05:10:47 PM
#125900   IT'S OFTEN SAID: "THOSE WHO CAN DO. THOSE Trendliner 10/20/16 05:02:09 PM
#125899   One would think with all of these wonderful Its_lose_not_loose 10/20/16 04:34:12 PM
#125898   That's correct. Seymour is a geriatric clown. arvitar 10/20/16 04:23:54 PM
#125897   He was founder and CEO of the largest BigKahuna 10/20/16 03:45:32 PM
#125896   Seymour has never authored a single scientific publication arvitar 10/20/16 02:35:53 PM
#125895   I AM AFRAID YOU ARE RIGHT ILNL Trendliner 10/20/16 02:17:55 PM
#125894   Sayeth Seymour: "Facts? We don't need no stinkin' facts!" Its_lose_not_loose 10/20/16 01:15:45 PM
#125893   A fact that does matter: arvitar 10/20/16 01:06:05 PM
#125891   FDA Conference Call... Its_lose_not_loose 10/20/16 10:36:35 AM
#125890   EXCELLENT ILNL Trendliner 10/20/16 10:10:14 AM
#125889   YOU ARE CORRECT ILNL Trendliner 10/20/16 09:25:06 AM
#125888   I've got a conference call with the FDA Its_lose_not_loose 10/20/16 09:11:40 AM
#125887   This is absolute bullshit: Its_lose_not_loose 10/20/16 09:06:07 AM
#125886   Let's ignore that the FDA says that preclinical drrawmd65 10/20/16 12:13:48 AM
#125885   Instead of referring to a book that's ten drrawmd65 10/20/16 12:10:32 AM
#125884   I'm sorry. I don't read caps-locked bold arvitar 10/19/16 11:36:03 PM
#125883   SOUNDS REASONABLE Trendliner 10/19/16 11:12:39 PM
#125881   99% CERTAINTY CEO LETTER COMES OUT WITHIN 3 WEEKS!!!! arvitar 10/19/16 07:58:06 PM
#125880   THE REAL ISSUE IS THIS Trendliner 10/19/16 07:22:51 PM
#125879   THANKS, KMBJN.....VERY INTERESTING Trendliner 10/19/16 06:27:48 PM
#125878   Right, let's look again at my link to KMBJN 10/19/16 06:19:20 PM
#125877   Instead of referring to a book that's ten arvitar 10/19/16 05:53:29 PM
#125876   You're claiming it's a lie for NNVC to KMBJN 10/19/16 05:27:56 PM
#125875   ....and yet nowhere does it say it was drrawmd65 10/19/16 04:56:13 PM
#125874   Where does it say the FDA required them arvitar 10/19/16 04:51:49 PM
#125873   When AVIBio said that they were doing preclinical KMBJN 10/19/16 04:40:30 PM
#125872   If NNVC and its crew called efficacy studies drrawmd65 10/19/16 04:28:56 PM
#125871   An IND application does not require efficacy data. arvitar 10/19/16 04:05:36 PM
#125870   Nobody is lying. The truth is that KMBJN 10/19/16 04:00:49 PM
#125867   The only company that is lying is NNVC drrawmd65 10/19/16 02:32:38 PM
#125865   All the other companies like NNVC developing flu KMBJN 10/19/16 01:32:37 PM
#125863   Comparing a company that actually does anti viral NewMoney 10/19/16 12:49:43 PM
#125862   Ansun, NNVC's competitor that is far more competent, drrawmd65 10/19/16 11:39:48 AM
#125861   Well to be fair, as the headline suggests, drrawmd65 10/19/16 08:00:30 AM
#125860   He has indeed found several different ways to loanranger 10/19/16 07:00:59 AM
#125859   KazMmjBJonesN, thank you for the exhaustive research you Its_lose_not_loose 10/19/16 06:29:24 AM
#125857   In the end - the only thing that JG36 10/19/16 12:09:50 AM
#125856   Here's another interesting flu treatment in development, ASN2: KMBJN 10/18/16 11:21:19 PM
#125854   The sheer buffoonery of it all is that arvitar 10/18/16 09:45:26 PM
#125853   "the letter itself isn't a thing that is loanranger 10/18/16 04:53:29 PM
#125852   Yeah - had an arvitar 10/18/16 03:58:45 PM
#125851   While I admittedly look forward to (finally) seeing drkazmd65 10/18/16 03:48:16 PM